Linda Laux

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

Orrin Devinsky, J. Helen Cross, Linda Laux et al. · New England Journal of Medicine · 2017 · 1.7K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

Orrin Devinsky, Eric D. Marsh, Daniel J. Friedman et al. · The Lancet Neurology · 2015 · 895 citations

Medicine, Pharmacology, Pharmacotherapy +13

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

Elizabeth A. Thiele, Eric D. Marsh, Jacqueline A. French et al. · The Lancet · 2018 · 887 citations

Medicine, Neurology, Pharmacology +9

Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome

Orrin Devinsky, Anup D. Patel, Elizabeth A. Thiele et al. · Neurology · 2018 · 451 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +16

Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial

Lieven Lagae, Joseph Sullivan, Kelly G. Knupp et al. · The Lancet · 2019 · 366 citations

Medicine, Pharmacology, Pharmacotherapy +9